211 related articles for article (PubMed ID: 7568626)
21. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
22. Argyreia nervosa (Burm. f.): receptor profiling of lysergic acid amide and other potential psychedelic LSD-like compounds by computational and binding assay approaches.
Paulke A; Kremer C; Wunder C; Achenbach J; Djahanschiri B; Elias A; Schwed JS; Hübner H; Gmeiner P; Proschak E; Toennes SW; Stark H
J Ethnopharmacol; 2013 Jul; 148(2):492-7. PubMed ID: 23665164
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of dopamine receptors in insect (Apis mellifera) brain.
Kokay IC; Mercer AR
Brain Res; 1996 Jan; 706(1):47-56. PubMed ID: 8720491
[TBL] [Abstract][Full Text] [Related]
24. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
Gresch PJ; Strickland LV; Sanders-Bush E
Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
[TBL] [Abstract][Full Text] [Related]
25. Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).
Nichols DE; Frescas S; Marona-Lewicka D; Kurrasch-Orbaugh DM
J Med Chem; 2002 Sep; 45(19):4344-9. PubMed ID: 12213075
[TBL] [Abstract][Full Text] [Related]
26. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
27. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
28. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain.
Jin LQ; Goswami S; Cai G; Zhen X; Friedman E
J Neurochem; 2003 Apr; 85(2):378-86. PubMed ID: 12675914
[TBL] [Abstract][Full Text] [Related]
29. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
[TBL] [Abstract][Full Text] [Related]
30. Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
Giacomelli S; Palmery M; Romanelli L; Cheng CY; Silvestrini B
Life Sci; 1998; 63(3):215-22. PubMed ID: 9698051
[TBL] [Abstract][Full Text] [Related]
31. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
Dong ZJ; Chen LJ; Jin GZ; Creese I
Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
[TBL] [Abstract][Full Text] [Related]
32. 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors.
Engel G; Müller-Schweinitzer E; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):328-36. PubMed ID: 6728042
[TBL] [Abstract][Full Text] [Related]
33. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
34. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB
J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308
[TBL] [Abstract][Full Text] [Related]
35. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
[TBL] [Abstract][Full Text] [Related]
36. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains.
Ouagazzal A; Grottick AJ; Moreau J; Higgins GA
Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of stably expressed human dopamine D1a and D1b receptors: atypical behavior of the dopamine D1b receptor.
Pedersen UB; Norby B; Jensen AA; Schiødt M; Hansen A; Suhr-Jessen P; Scheideler M; Thastrup O; Andersen PH
Eur J Pharmacol; 1994 Mar; 267(1):85-93. PubMed ID: 8206133
[TBL] [Abstract][Full Text] [Related]
38. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
Buckholtz NS; Zhou DF; Freedman DX; Potter WZ
Neuropsychopharmacology; 1990 Apr; 3(2):137-48. PubMed ID: 1969270
[TBL] [Abstract][Full Text] [Related]
39. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
40. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
De Gregorio D; Comai S; Posa L; Gobbi G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
